Cargando…
Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer
Thyroid hormone receptor beta (THRB) gene is commonly deregulated in cancers and, as strengthened by animal models, postulated to play a tumor-suppressive role. Our previous studies revealed downregulation of THRB in clear cell renal cell carcinoma (ccRCC), but the culpable mechanisms have not been...
Autores principales: | Wojcicka, Anna, Piekielko–Witkowska, Agnieszka, Kedzierska, Hanna, Rybicka, Beata, Poplawski, Piotr, Boguslawska, Joanna, Master, Adam, Nauman, Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029725/ https://www.ncbi.nlm.nih.gov/pubmed/24849932 http://dx.doi.org/10.1371/journal.pone.0097624 |
Ejemplares similares
-
Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010) -
MiR-224 Targets the 3′UTR of Type 1 5′-Iodothyronine Deiodinase Possibly Contributing to Tissue Hypothyroidism in Renal Cancer
por: Boguslawska, Joanna, et al.
Publicado: (2011) -
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
por: Kędzierska, Hanna, et al.
Publicado: (2016) -
TGF-β1 affects the renal cancer miRNome and regulates tumor cells proliferation
por: Hanusek, Karolina, et al.
Publicado: (2022) -
Correction: Kędzierska, H., et al. Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer. Int. J. Mol. Sci. 2016, 17, 1598
por: Kędzierska, Hanna, et al.
Publicado: (2020)